Hepatitis C Treatment Is Cost-effective For The US Prison Population
Sunday, October 26, 2008 - 10:14
in Health & Medicine
Treating all US prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study.